EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105. A total of 85 filers reported holding EDGEWISE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,063,333 | -26.1% | 360,093 | 0.0% | 0.02% | -27.3% |
| Q2 2023 | $2,790,721 | +16.2% | 360,093 | 0.0% | 0.03% | 0.0% |
| Q1 2023 | $2,401,820 | -25.4% | 360,093 | +0.0% | 0.03% | -23.3% |
| Q4 2022 | $3,219,214 | -39.4% | 360,091 | -33.3% | 0.04% | -41.9% |
| Q3 2022 | $5,312,000 | -13.5% | 539,864 | -30.1% | 0.07% | -22.1% |
| Q2 2022 | $6,144,000 | +75.9% | 771,797 | +114.3% | 0.10% | +66.7% |
| Q1 2022 | $3,493,000 | -43.3% | 360,093 | -10.6% | 0.06% | -35.2% |
| Q4 2021 | $6,156,000 | +2.5% | 402,849 | +11.3% | 0.09% | -10.2% |
| Q3 2021 | $6,006,000 | -20.6% | 361,821 | +2.1% | 0.10% | -30.5% |
| Q2 2021 | $7,561,000 | -34.9% | 354,489 | -0.8% | 0.14% | -45.3% |
| Q1 2021 | $11,616,000 | – | 357,429 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,553,661 | $15,071,000 | 7.43% |
| Cormorant Asset Management, LP | 4,682,874 | $45,424,000 | 3.49% |
| Novo Holdings A/S | 5,587,207 | $54,196,000 | 2.86% |
| Orbimed Advisors | 13,944,680 | $135,263,000 | 2.19% |
| Opaleye Management Inc. | 303,000 | $2,939,000 | 0.91% |
| DAFNA Capital Management LLC | 356,750 | $3,460,000 | 0.90% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,933,137 | $38,151,000 | 0.85% |
| EcoR1 Capital, LLC | 2,359,808 | $22,890,000 | 0.72% |
| RA Capital Management | 2,613,623 | $25,352,000 | 0.55% |
| HighVista Strategies LLC | 59,733 | $579,000 | 0.37% |